ImpriMed
5 known investors
Find your way into ImpriMed
ImpriMedicine provides live-cell-based predictive analytics to identify effective drugs for treating blood cancers in dogs and cats, offering patient-specific drug response predictions. The company serves veterinary oncology and drug development efforts in the animal health field.
Investors · 5
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through ImpriMed went on to found or lead other companies.
In the news
Frequently asked questions
- What does ImpriMed do?
- ImpriMedicine provides live-cell-based predictive analytics to identify effective drugs for treating blood cancers in dogs and cats, offering patient-specific drug response predictions. The company serves veterinary oncology and drug development efforts in the animal health field.
- Who are ImpriMed's investors?
- ImpriMed's investors include Blue Bear Ventures, DFJ DragonFund, Draper Associates, Han River Partners, Sazze.